Skip to main content
IVVD logo

IVVD · Invivyd, Inc. · Earnings Calls, Transcripts & Webcasts

Track IVVD — free
$0.41 -0.03 (-7.45%) At close · Nov 20 Play latest call Q1 2026 earnings call transcript
Market Cap
$122.01M
Shares
295.63M
Volume · Nov 20 5.32M Avg daily vol (3M) 5.21M

Invivyd, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Invivyd, Inc. (IVVD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q2
2026-09-29
Invivyd, Inc. (IVVD) Q2 2026 Earnings Call
Revenue
$14.29M
▲ 21.2% YoY
Diluted EPS
$-0.14
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-14
Invivyd, Inc. (IVVD) September 14, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Invivyd, Inc. (IVVD) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-14
Invivyd, Inc. (IVVD) Q1 2026 Earnings Call Transcript
Confident tone Public education and messaging Monoclonal antibody platform strategy Pivotal program recruitment and timing
Revenue
$13.74M
▲ 21.6% YoY
Diluted EPS
$-0.13
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-04-09
Invivyd, Inc. (IVVD) April 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-05
Invivyd, Inc. (IVVD) Q4 2025 Earnings Call Transcript
Positive tone VYD-2311 COVID Prophylaxis Program Pemgarda Commercial Performance Regulatory and Public Health Landscape
Revenue
$17.21M*
▲ 24.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Invivyd, Inc. (IVVD) Q3 2025 Earnings Call Transcript
Confident tone VYD2311 pivotal program Discovery pipeline (RSV, nasal antibodies, measles) PEMGARDA commercial franchise
Revenue
$13.13M
▲ 41.2% YoY
Diluted EPS
$-0.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2025-10-30
Invivyd, Inc. (IVVD) October 30, 2025 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q1
2025-05-15
Invivyd, Inc. (IVVD) Q1 2025 Earnings Call Transcript
Confident tone SARS-CoV-2 epitope durability Regulatory strategy and EUA-to-BLA path PEMGARDA commercial transition and growth
Revenue
$11.30M
Diluted EPS
$-0.14
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-03
Invivyd, Inc. (IVVD) Q4 2024 Earnings Call
Revenue
$13.82M*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Invivyd, Inc. (IVVD) Q3 2024 Earnings Call Transcript
Cautious tone FDA/regulatory headwind and KP.3.1.1 susceptibility issue Pemivibart (PEMGARDA) clinical efficacy and CANOPY data Treatment EUA / immunobridging regulatory pathway
Revenue
$9.30M
Diluted EPS
$-0.51
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Invivyd, Inc. (IVVD) Q2 2024 Earnings Call Transcript
Positive tone Immunocompromised patient population and unmet need PEMGARDA commercial launch and net revenue Pipeline molecule VYD2311
Revenue
$2.26M
Diluted EPS
$-0.40
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Invivyd, Inc. (IVVD) Q1 2024 Earnings Call Transcript
Confident tone PEMGARDA commercial launch Treatment opportunity and competition Regulatory pathway and FDA alignment
Revenue
$0
Diluted EPS
$-0.38
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-25
Invivyd, Inc. (IVVD) Q4 2023 Earnings Call
Net income
−$73.65M*
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Invivyd, Inc. (IVVD) Q3 2023 Earnings Call Transcript
Revenue
$0
Diluted EPS
$-0.36
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Invivyd, Inc. (IVVD) Q2 2023 Earnings Call Transcript
Revenue
$0
Diluted EPS
$-0.46
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Invivyd, Inc. (IVVD) Q1 2023 Earnings Call Transcript
Net income
−$35.32M
Diluted EPS
$-0.32
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-23
Invivyd, Inc. (IVVD) Q4 2022 Earnings Call Transcript
Net income
−$44.57M*
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Invivyd, Inc. (IVVD) Q3 2022 Earnings Call Transcript
Net income
−$45.09M
Diluted EPS
$-0.42
Audio Transcript Slides 8-K10-Q
Showing 1–19 of 19 webcasts
Key facts CIK 1832038 CUSIP 00534A102 13F (30d) 144 filings 126 filers Visit website Investor relations